Self-reported number of cigarettes used during treatment showed a trend for reduced use of tobacco only in the nabiximols group ( S2B Fig ), whereas the number of cigarettes in the placebo group remained similar before (week 0) and at the end of treatment (week 12).
← all excerpts
Nabiximols combined with motivational enhancement/cognitive behavioral therapy for the treatment of cannabis dependence: A pilot randomized clinical trial.
1
—
—